Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder

Trial Profile

Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Jun 2010

At a glance

  • Drugs Carbamazepine; Lithium; Olanzapine; Valproic acid
  • Indications Bipolar I disorders
  • Focus Therapeutic Use
  • Acronyms BMAC
  • Sponsors Eli Lilly
  • Most Recent Events

    • 09 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Oct 2008 Checked against the ClinicalTrials.gov record.
    • 28 Sep 2008 Planned number of patients is now 143 according to the ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top